About us
Research Library
Company Pages
Allergy Therapeutics
ANGLE
Arecor Therapeutics
Avacta
Futura Medical
HUTCHMED
MaxCyte
Nexstim
Redx Pharma
Scancell
Contact us
More Company News
Nexstim
Potential new therapeutic use for SmartFocus nTMS in Postsurgical Rehabilitation of Paresis
17 May 2021
Read More
Nexstim
New NBS System order from a leading California-based academic hospital
07 May 2021
Read More
Nexstim
NBT System order from a new therapy customer in Finland
29 Apr 2021
Read More
Nexstim
Q121 business and clinical update
22 Apr 2021
Read More
Nexstim
Final results of successful rights issue
07 Apr 2021
Read More
Nexstim
Update on promising MDD treatment results
12 Mar 2021
Read More
Nexstim
Subscription rights issue of €6.6m
08 Mar 2021
Read More
Nexstim
Two new NBS orders in Norway & US
04 Mar 2021
Read More
Nexstim
Encouraging results from initial pilot study in severe depression
03 Mar 2021
Read More
Nexstim
FY20 financial statements
26 Feb 2021
Read More
1
2
3
4
5
6
…
13
Return to Nexstim
© 2019-22 Trinity Delta. All rights reserved. Trinity Delta is regulated by the Financial Conduct Authority (Reference number: 725161).
About us
Research Library
Company Pages
▼
Allergy Therapeutics
ANGLE
Arecor Therapeutics
Avacta
Futura Medical
HUTCHMED
MaxCyte
Nexstim
Redx Pharma
Scancell
Contact us